Application of sonchus oleraceus extract in preparation of medicine for treating allergic diseases

The process parameters of the extract of chicodile extract were optimized by aqueous phase enzymatic extraction, and the problem of insufficient application of chicodile in anti-allergic drugs was solved. Chicodile extract with significant anti-allergic effects was prepared for allergicity Treatment of rhinitis and skin allergies.

CN118924801APending Publication Date: 2024-11-12BEIJING XUANZHIDA BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411210281.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art has not yet effectively utilized chicodile extract as an anti-allergic drug, and there is a lack of treatment options for allergic diseases.

Method used

The extract of chicory vegetable is prepared by aqueous enzymatic extraction. The specific steps include cleaning, crushing, enzymatic decomposition, decompression extraction and spray drying. The optimization process parameters are solid-liquid ratio 1:10g/mL, and the amount of papain added 600U/ g, pH value of the enzymatic lysis system is 6.5, enzymatic lysis temperature is 60℃, and extraction is 75℃ for 1 h under reduced pressure.

Benefits of technology

The prepared chicory extract has good anti-allergic effects and can effectively prevent and treat allergic reactions, especially in allergic rhinitis and skin allergies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924801A_ABST
    Figure CN118924801A_ABST
Patent Text Reader

Abstract

The invention discloses an application of a sonchus oleraceus extract in preparation of drugs for treating allergic diseases. Belongs to the technical field of natural extracts. Through research on a preparation process of the sonchus oleraceus extract, the proper preparation process of the sonchus oleraceus extract is determined as follows: the solid-to-liquid ratio is 1: 10g / mL, the papain addition amount is 600U / g, the pH value of an enzymolysis system is 6.5, the enzymolysis temperature is 60 DEG C, enzymolysis is performed for 1 hour, and decompression extraction is performed for 1 hour at 75 DEG C. Under the conditions, the sonchus oleraceus extract has a good anti-allergic effect; a new raw material and a new product are provided for anti-allergic prevention and treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of natural extracts, and more particularly to application of a chicory extract in preparing medicines for treating allergic diseases. Background Art

[0002] Allergic diseases can occur at all ages from newborns to the elderly, and often have a clear genetic tendency. Among allergic diseases, immediate allergic reactions are more common, and their main types include skin allergic reactions, respiratory allergic reactions, digestive tract allergic reactions and anaphylactic shock. Immediate allergic reactions are mediated by IgE. Antigens (allergens) combine with specific IgE (tissue mast cells and blood basophils) to trigger the release of inflammatory mediators, including existing inflammatory mediators (such as histamine, proteases, chemokines) and newly synthesized other mediators (such as prostaglandins, leukotrienes, platelet-activating factor, interleukins). These inflammatory mediators can lead to vasodilation, increased capillary permeability, hypersecretion of mucus, contraction of smooth muscles, and infiltration of eosinophils, helper T cells (TH2) and other inflammatory cells in tissues.

[0003] Chicory was first recorded in Shennong's Herbal Classic. It has high medicinal value and can treat anorexia, nourish the stomach, promote urination, improve eyesight, treat hematuria and hemorrhoid fistula, etc. However, there is no report on the anti-allergic effect of chicory.

[0004] In summary, how to provide a chicory extract with anti-allergic effect and a preparation method thereof is a problem that those skilled in the art urgently need to solve. Summary of the invention

[0005] In view of this, the present invention provides the use of a chokeberry extract in preparing a medicine for treating allergic diseases.

[0006] In order to achieve the above object, the present invention adopts the following technical solution:

[0007] Application of sowthistle extract in preparing medicine for treating allergic diseases.

[0008] Furthermore, the chicory extract is prepared by aqueous enzymatic extraction.

[0009] Furthermore, the preparation method of the chicory extract is as follows:

[0010] (1) Wash the aerial part of the chicory, dry it in the shade, crush it, sieve it, and set it aside;

[0011] (2) using water as an extraction solvent, adding papain, performing enzymatic hydrolysis and vacuum extraction to obtain a crude extract;

[0012] (3) concentrating the crude extract under reduced pressure to obtain a concentrated solution;

[0013] (4) spray-drying the concentrated solution to obtain the chicory extract.

[0014] Furthermore, in step (2),

[0015] Solid-liquid ratio 1:8~1:10g / mL;

[0016] Papain addition amount 200~600U / g;

[0017] The pH value of the enzymatic hydrolysis system is 6-7;

[0018] The enzymatic hydrolysis temperature is 55-60°C and the enzymatic hydrolysis time is 1h;

[0019] Extract at 65-75℃ under reduced pressure for 1-2h.

[0020] Furthermore, in step (2),

[0021] Solid-liquid ratio 1:10 g / mL;

[0022] Papain added at 600U / g;

[0023] The pH value of the enzymatic hydrolysis system was 6.5;

[0024] The enzymatic hydrolysis temperature was 60°C and the enzymatic hydrolysis time was 1 h;

[0025] Extract under reduced pressure at 75°C for 1 h.

[0026] Furthermore, in step (3), the conditions for reduced pressure concentration are a vacuum degree of -0.1 MPa and a temperature of 60°C.

[0027] Furthermore, in the step (4), the spray drying conditions are 125° C., a feed rate of 30 mL / min, and an air extraction volume of 100%.

[0028] It can be seen from the above technical solution that, compared with the prior art, the beneficial effects achieved by the present invention are:

[0029] The present invention studies the preparation process of the chicory extract and determines that the suitable preparation process of the chicory extract is as follows: the solid-liquid ratio is 1:10 g / mL, the amount of papain added is 600 U / g, the pH value of the enzymatic hydrolysis system is 6.5, the enzymatic hydrolysis temperature is 60°C, the enzymatic hydrolysis is performed for 1 hour, and the reduced pressure extraction is performed at 75°C for 1 hour. Under these conditions, the chicory extract has a good anti-allergic effect, and provides new raw materials and new products for the prevention and treatment of anti-allergy. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.

[0031] Figure 1 The accompanying drawing shows the chicory extract prepared in Example 8 of the present invention. DETAILED DESCRIPTION

[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] The drugs required for the present invention are conventional experimental drugs, which are purchased from commercial channels; the experimental methods not mentioned are conventional experimental methods and will not be described in detail here.

[0034] Example 1

[0035] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0036] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:8 (g / mL), add 200 U / g papain, pH 6, enzymatic hydrolysis at 55°C for 1 h; then extract under reduced pressure at 65°C for another 1 h;

[0037] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0038] 4. The concentrated solution was spray dried (125° C., feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract for later use.

[0039] Example 2

[0040] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0041] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:8 (g / mL), add 400 U / g papain, pH 6, enzymatic hydrolysis at 55°C for 1 h; then extract under reduced pressure at 65°C for another 1 h;

[0042] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0043] 4. The concentrated solution was spray dried (125° C., feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract for later use.

[0044] Example 3

[0045] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0046] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:8 (g / mL), add 600 U / g papain, pH 6, enzymatically hydrolyze at 55°C for 1 h; then extract at 65°C under reduced pressure for another 1 h;

[0047] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0048] 4. The concentrated solution was spray dried (125° C., feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract for later use.

[0049] Example 4

[0050] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0051] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:8 (g / mL), add 600 U / g papain, pH 6.5, enzymatically hydrolyze at 55°C for 1 h; then extract under reduced pressure at 65°C for another 1 h;

[0052] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0053] 4. The concentrated solution was spray dried (125° C., feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract for later use.

[0054] Example 5

[0055] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0056] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:8 (g / mL), add 600 U / g papain, pH 7.0, and enzymatically hydrolyze at 55°C for 1 h; then extract under reduced pressure at 65°C for another 1 h;

[0057] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0058] 4. The concentrated solution was spray dried (125° C., feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract for later use.

[0059] Example 6

[0060] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0061] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:10 (g / mL), add 600 U / g papain, pH 6.5, enzymatically hydrolyze at 60°C for 1 h; then extract under reduced pressure at 65°C for another 1 h;

[0062] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0063] 4. The concentrated solution was spray dried (125° C., feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract for later use.

[0064] Example 7

[0065] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0066] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:10 (g / mL), add 600 U / g papain, pH 6.5, enzymatically hydrolyze at 60 ° C for 1 h; then extract under reduced pressure at 70 ° C for another 1 h;

[0067] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0068] 4. The concentrated solution was spray dried (125° C., feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract for later use.

[0069] Example 8

[0070] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0071] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:10 (g / mL), add 600 U / g papain, pH 6.5, enzymatically hydrolyze at 60 ° C for 1 h; then extract under reduced pressure at 75 ° C for another 1 h;

[0072] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0073] 4. The concentrated solution was spray dried (125°C, feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract (eg Figure 1 as shown), for backup.

[0074] Comparative Example 1

[0075] 1. Dry the aerial part of the chicory in the shade, crush it, pass it through a 10-mesh sieve and store it in a sealed bag for later use;

[0076] 2. Weigh 500 g of chicory powder, use water as the extraction solvent, solid-liquid ratio 1:6 (g / mL), pH 5, and extract under reduced pressure at 50°C for 1 h;

[0077] 3. Take the supernatant and concentrate it under reduced pressure (-0.1 MPa, temperature 60°C) to obtain a concentrated solution (relative density 1.1);

[0078] 4. The concentrated solution was spray dried (125° C., feed rate 30 mL / min, suction volume 100%) to obtain the chicory extract for later use.

[0079] Experiment 1

[0080] Anti-allergic effect experiment

[0081] SPF BN (Brown-Norway) rats, male, weight (200±10) g. Adaptive feeding for 7 days with standard diet and free access to water. Ambient temperature: 24±1°C, humidity: 55±10%.

[0082] The allergic reaction model was constructed by ovalbumin (OVA) injection. OVA was purchased from Sigma, item number A5503, with a purity of >98%. 1g of OVA was dissolved in 100mL of 0.1M PBS to obtain an OVA solution. Construction method: 1mL of OVA solution was injected intraperitoneally on the 1st, 7th, and 14th days after the start of the experiment, and 2mL of OVA solution was injected intraperitoneally on the 21st day. The score was statistically calculated 7 days after the last intraperitoneal OVA injection, blood was collected from the tail vein, and the animals were killed.

[0083] Allergy symptom scoring: Allergy symptom scoring was performed before the mice were killed. The specific scoring criteria are as follows:

[0084] 0 points: no symptoms;

[0085] 1 point: scratching the face;

[0086] 2 points: facial redness and swelling, shortness of breath, and mental depression;

[0087] 3 points: tearing, rash around the mouth and tail, asthma, and difficulty breathing;

[0088] 4 points: inactivity, muscle contraction, spasm;

[0089] 5 points: Death, shock.

[0090] The scores of mice in each group were counted and the average value was calculated.

[0091] A total of 11 groups were set up, with 7 mice in each group. The gavage samples were the chicory extracts prepared in each embodiment / comparative example, and the gavage concentration was 0.3 g / kg body weight (after calculating the amount of chicory extract according to body weight, the chicory extract was dissolved in physiological saline and gavage was performed). The specific treatment method of each group is as follows:

[0092] ① Blank control group: 1 mL of 0.1 M PBS was injected intraperitoneally on the 1st, 7th, 14th and 21st days after the start of the experiment, and 5 mL of normal saline was gavaged daily;

[0093] ② Allergic reaction model group: The model was constructed according to the above model construction method, and 5 mL of normal saline was gavaged daily;

[0094] ③ Group 1: The model was constructed according to the aforementioned model construction method, and 5 mL of the chicory extract of Example 1 was intragastrically administered daily;

[0095] ④ Group 2 of Example 2: The model was constructed according to the aforementioned model construction method, and 5 mL of the chicory extract of Example 2 was intragastrically administered daily;

[0096] ⑤ Group 3 of Example: The model was constructed according to the aforementioned model construction method, and 5 mL of the chicory extract of Example 3 was intragastrically administered daily;

[0097] ⑥ Group 4 of Example: The model was constructed according to the aforementioned model construction method, and 5 mL of the chicory extract of Example 4 was intragastrically administered daily;

[0098] ⑦ Group 5: The model was constructed according to the aforementioned model construction method, and 5 mL of the chicory extract of Example 5 was intragastrically administered daily;

[0099] ⑧ Group 6 of Example: The model was constructed according to the aforementioned model construction method, and 5 mL of the chicory extract of Example 6 was intragastrically administered daily;

[0100] ⑨ Group 7 of Example: The model was constructed according to the aforementioned model construction method, and 5 mL of the chicory extract of Example 7 was intragastrically administered daily;

[0101] ⑩ Group 8 of Example: The model was constructed according to the aforementioned model construction method, and 5 mL of the chicory extract of Example 8 was intragastrically administered daily;

[0102] Comparative Example 1 group: The model was constructed according to the above-mentioned model construction method, and 5 mL of the chicory extract of Comparative Example 1 was intragastrically administered daily.

[0103] Detection indicators: ELISA kit detects IgE, IL-4, IL-13, IL-12, IFN-γ, TNF-α and histamine (HIS). The detection steps are carried out according to the instructions.

[0104] The results are shown in Table 1.

[0105] Table 1 Test results of anti-allergic effect of chicory extract

[0106]

[0107]

[0108] Table 1 Appendix

[0109] Evaluation indicators Example 5 Group Example 6 Group Example 7 Group Example 8 Group Comparative Example 1 Allergy symptom score 2.6±0.3 1.1±0.2 0.7±0.1 0.5±0.1 3.9±0.4 IgE (ng / mL) 18.9±3.1 11.4±1.0 9.1±0.8 8.9±0.2 26.1±2.2 HIS (ng / mL) 12.4±1.8 9.8±0.6 8.3±2.0 7.7±0.1 14.7±3.4 IL-4 (pg / mL) 128.8±21.3 115.5±10.3 107.1±14.5 91.0±8.3 138.3±17.6 TNF-α(pg / mL) 498.7±29.1 327.3±14.4 298.5±22.3 264.5±12.7 601.8±37.4 IFN-γ (pg / mL) 632.6±31.7 585.1±23.7 551.2±18.8 534.2±23.4 758.2±38.6 IL-12 (pg / mL) 8.6±1.0 11.2±3.6 12.8±2.3 14.6±1.0 6.5±0.3 IL-13 (pg / mL) 152.6±30.1 105.3±16.4 91.4±11.7 87.3±12.5 241.4±23.7

[0110] According to Table 1, the effects of relieving allergic symptoms in Example 1 to 8 groups were better than those in Comparative Example 1 group, and the effect of Example 8 group was better. The IgE content of the allergic reaction model group was much higher than that of the blank control group, indicating that the mice in the allergic reaction model group had an allergic reaction; the IgE content of Example 1 to 8 groups and Comparative Example 1 group decreased significantly, indicating that both Example 1 to 8 groups and Comparative Example 1 group played a certain anti-allergic role, and the effects of Example 1 to 8 groups were better than those in Comparative Example 1 group, and the effect of Example 8 group was the best. HIS, IL-4, TNF-α, IFN-γ, and IL-13 are serum inflammatory factors of allergic reactions, which increased significantly in the allergic reaction model group; after intragastric administration of the chicory extract prepared in Examples 1 to 8, the serum inflammatory factors of mice decreased significantly, which was greatly improved compared with the Comparative Example 1 group, and the anti-allergic effect of Example 8 group was the best. IL-12 is an anti-inflammatory factor, which decreased significantly in the allergic reaction model group; after intragastric administration of the chicory extract prepared in Examples 1 to 8, IL-12 was significantly downregulated, which was greatly improved compared with the Comparative Example 1 group, and the anti-allergic effect of Example 8 group was the best.

[0111] Through the study of the preparation process of chicory extract, the influence of various process parameters on the anti-allergic effect of chicory extract was investigated, and the suitable preparation process of chicory extract was determined as follows: solid-liquid ratio of 1:10g / mL, papain addition of 600U / g, enzymatic hydrolysis system pH of 6.5, enzymatic hydrolysis temperature of 60℃, enzymatic hydrolysis for 1h, and reduced pressure extraction at 75℃ for 1h. Under these conditions, chicory extract has good anti-allergic effect and provides new raw materials and new products for the prevention and treatment of anti-allergy.

[0112] Application Example 1

[0113] Allergic rhinitis

[0114] The modeling method and drug administration method were the same as those in Experiment 1.

[0115] After nasal provocation, rats showed nasal scratching, sneezing, and rhinorrhoea. The scoring criteria are as follows:

[0116] Scratching the nose 1 to 5 times was 1 point, 6 to 15 times was 2 points, and >15 times was 3 points;

[0117] Sneezing 1 to 3 times is 1 point, 4 to 10 times is 2 points, and >10 times is 3 points;

[0118] Nasal overflow: 1 point if it flows to the anterior nasal aperture, 2 points if it flows out of the anterior nasal aperture, and 3 points if it fills the entire face.

[0119] The scores of mice in each group were counted and the average value was calculated.

[0120] The results are shown in Table 2.

[0121] Table 2 Effect of chicory extract on the behavior of rats with rhinitis

[0122] Group Nose scratching action sneeze Rhinorrhoea Blank control group 0.60±0.30 0.39±0.14 0.21±0.10 Allergic reaction model group 2.83±0.38 2.55±0.21 2.64±0.56 Example 1 Group 2.14±0.42 1.87±0.51 1.91±0.63 Example 2 Group 1.98±0.37 1.49±0.28 1.53±0.39 Example 3 Group 1.60±0.36 1.07±0.54 1.12±0.28 Example 4 Group 1.47±0.51 0.93±0.11 0.92±0.34 Example 5 Group 1.83±0.46 1.18±0.60 1.26±0.49 Example 6 Group 1.19±0.42 0.76±0.23 0.69±0.31 Example 7 Group 0.69±0.15 0.48±0.211 0.27±0.18 Example 8 Group 0.65±0.12 0.40±0.10 0.23±0.14 Comparative Example 1 2.54±0.73 2.09±0.35 2.21±0.46

[0123] As shown in Table 2, compared with the allergic reaction model group, the behavioral scores of allergic rhinitis in rats in Example 1 to 8 and Comparative Example 1 were all reduced, especially in Example 8, which had the most significant effect on the behavioral effects of allergic rhinitis in rats, and the best effect.

[0124] Application Example 2

[0125] Anti-skin allergy

[0126] Antipruritic experiment: 110 healthy Kunming mice, half male and half female, weighing 18-22 grams. Randomly divided into 11 groups, 10 mice in each group. 8% sodium sulfide alcohol solution was used to remove hair on the back (2cm×3cm), and the test drug was applied to the skin of the depilated area once a day for 7 consecutive days. The allergic reaction model group and the blank control group were coated with an equal amount of normal saline. 40 minutes after the last administration, normal saline was injected subcutaneously at the back of the neck. The number of lickings in each group within 10 minutes was recorded (if the licking was continuous until a brief pause, it was counted as 1 licking).

[0127] Determination of skin histamine concentration: After the antipruritic experiment, the mice were immediately killed by cervical dislocation, and the sensitized skin of the same area (1.5 cm×2 cm) was cut off and prepared into tissue homogenate; the histamine concentration of the tissue homogenate was determined by enzyme-linked immunosorbent assay.

[0128] The results are shown in Table 3.

[0129] Table 3 Anti-skin allergy effect of chicory extract

[0130] Group Number of licks within 10 minutes Histamine concentration (μg / gprotein) Blank control group - 2.76±0.42 Allergic reaction model group 47±2 5.75±0.67 Example 1 Group 37±6 4.82±0.65 Example 2 Group 34±4 4.09±0.73 Example 3 Group 23±3 3.67±0.53 Example 4 Group 20±2 3.38±0.81 Example 5 Group 29±6 3.88±0.64 Example 6 Group 19±1 3.16±0.77 Example 7 Group 15±2 2.98±0.52 Example 8 Group 13±1 2.87±0.39 Comparative Example 1 41±3 4.93±0.57

[0131] It can be seen from Table 3 that, compared with the allergic reaction model group, the groups of Examples 1 to 8 and the group of Comparative Example 1 all have anti-skin allergy effects, especially the group of Example 8 has the most significant and best anti-skin allergy effect.

[0132] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.

[0133] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. Application of chicory extract in the preparation of drugs for the treatment of allergic diseases.

2. The use according to claim 1, characterized in that The chicory extract is prepared by adopting an aqueous phase enzymatic extraction method.

3. The use according to claim 2, characterized in that The preparation method of the chicory extract is as follows: (1) Wash the aerial part of the chicory, dry it in the shade, crush it, sieve it, and set it aside; (2) using water as an extraction solvent, adding papain, performing enzymatic hydrolysis and vacuum extraction to obtain a crude extract; (3) concentrating the crude extract under reduced pressure to obtain a concentrated solution; (4) spray-drying the concentrated solution to obtain the chicory extract.

4. The use according to claim 3, characterized in that In the step (2), Solid-liquid ratio 1:8~1:10g / mL; Papain addition amount 200~600U / g; The pH value of the enzymatic hydrolysis system is 6-7; The enzymatic hydrolysis temperature is 55-60°C and the enzymatic hydrolysis time is 1h; Extract at 65-75℃ under reduced pressure for 1-2h.

5. The use according to claim 3, characterized in that In the step (2), Solid-liquid ratio 1:10 g / mL; Papain added at 600U / g; The pH value of the enzymatic hydrolysis system was 6.5; The enzymatic hydrolysis temperature was 60°C and the enzymatic hydrolysis time was 1 h; Extract under reduced pressure at 75°C for 1 h.

6. The use according to claim 3, characterized in that In the step (3), the conditions for reduced pressure concentration are a vacuum degree of -0.1 MPa and a temperature of 60°C.

7. The use according to claim 3, characterized in that In the step (4), the spray drying conditions are 125° C., a feed rate of 30 mL / min, and an air extraction volume of 100%.